However, the HER2-HER3 dimer frequency in HER2+ tumours was not consistently higher (Figure 2d), suggesting that HER2 IHC is not a reliable indicator of HER2-HER3 dimerization. This evidence concerns the gene ERBB3 and neoplasm.